American Portfolios Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.36M | Buy |
20,785
+905
| +5% | +$59.1K | 0.06% | 336 |
|
|
2022
Q2 | $1.21M | Buy |
19,880
+2,501
| +14% | +$152K | 0.05% | 381 |
|
|
2022
Q1 | $1.09M | Buy |
17,379
+1,634
| +10% | +$103K | 0.04% | 460 |
|
|
2021
Q4 | $1.19M | Buy |
15,745
+684
| +5% | +$51.8K | 0.04% | 432 |
|
|
2021
Q3 | $1.69M | Buy |
15,061
+582
| +4% | +$65.1K | 0.06% | 300 |
|
|
2021
Q2 | $2.34M | Sell |
14,479
-421
| -3% | -$68.2K | 0.09% | 224 |
|
|
2021
Q1 | $1.82M | Buy |
14,900
+1,337
| +10% | +$163K | 0.08% | 252 |
|
|
2020
Q4 | $2.08M | Buy |
13,563
+3,729
| +38% | +$571K | 0.11% | 189 |
|
|
2020
Q3 | $823K | Buy |
9,834
+3,545
| +56% | +$297K | 0.05% | 342 |
|
|
2020
Q2 | $462K | Buy |
6,289
+2,169
| +53% | +$159K | 0.03% | 456 |
|
|
2020
Q1 | $175K | Buy |
4,120
+324
| +9% | +$13.7K | 0.01% | 692 |
|
|
2019
Q4 | $231K | Buy |
3,796
+540
| +17% | +$32.9K | 0.02% | 696 |
|
|
2019
Q3 | $133K | Buy |
3,256
+74
| +2% | +$3.03K | 0.01% | 862 |
|
|
2019
Q2 | $150K | Buy |
3,182
+657
| +26% | +$30.9K | 0.01% | 824 |
|
|
2019
Q1 | $90.2K | Sell |
2,525
-900
| -26% | -$32.1K | 0.01% | 944 |
|
|
2018
Q4 | $97.9K | Buy |
3,425
+275
| +9% | +$7.86K | 0.01% | 736 |
|
|
2018
Q3 | $140K | Buy |
3,150
+50
| +2% | +$2.22K | 0.02% | 708 |
|
|
2018
Q2 | $182K | Buy |
+3,100
| New | +$182K | 0.02% | 586 |
|